Patent · US Active

Mitigation of contrast-induced nephropathy

US9421330B2 · kind B2 · utility

10Cited by
358References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 3, 2009
Grant dateAug 23, 2016
Priority date
Expiry dateOct 9, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/1082
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A system which includes a pressurizing mechanism to pressurize a fluid including a contrast enhancement agent for delivery to a patient and a control system in operative connection with the pressurizing mechanism. The control system includes a system to adjust control of fluid injection based upon a measurement of renal function of the patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.